Question about Williams Design [Design Issues]

posted by Bebac user – Egypt, 2025-02-25 21:30 (113 d 21:07 ago) – Posting: # 24376
Views: 1,343

Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,677 registered users;
36 visitors (0 registered, 36 guests [including 12 identified bots]).
Forum time: 19:37 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5